Results 181 to 190 of about 26,340 (266)

Aromaticity-driven laser photo-responses and binding efficiency in IAF-conjugated natural products for neurodegenerative disease targets. [PDF]

Signal Transduct Target Ther
Nik Zulkarnine NH, Faramarzi V, Hwang MT.   +2 more
europepmc   +1 more source

Aβ degradation—the inside story [PDF]

, 2014
Malcolm A. Leissring
core   +2 more sources

Angiotensin receptor-neprilysin inhibitor treatment in people with chronic obstructive pulmonary disease and heart failure. [PDF]

Commun Med (Lond)
Hsu WH, Shiau BW, Wu JY, Chuang MH, Tsai YW, Huang PY, Hu KC, Hsu W, Liu TH, Liao KM, Lai CC.   +10 more
europepmc   +1 more source

Beyond circulating cGMP: revisiting compartmentalized signaling in HFrEF. [PDF]

Int J Cardiol Heart Vasc
Pütz R, Herwig M, Delalat S, Sultana I, Akin I, Hamdani N, El-Battrawy I.   +6 more
europepmc   +1 more source

Metabolic alterations associated with sacubitril/valsartan treatment: a systematic review and meta-analysis. [PDF]

BMC Cardiovasc Disord
Abhari AP, Rezvanian P, Rahmani AR, Fakhrolmobasheri M, Meraji Far F, Ostadsharif N, Adelparvar F.   +6 more
europepmc   +1 more source

Correction to "The Interleukin-1α Stimulated Expression of the Wrinkle-Inducing Elastase Neprilysin in Adult Human Dermal Fibroblasts Is Mediated via the Intracellular Signaling Axis of ERK/JNK/c-Jun/c-Fos/AP-1". [PDF]

J Dermatol
europepmc   +1 more source

Angiotensin receptor-neprilysin inhibitors improve the outcome of lung cancer patients with hypertension undergoing immune checkpoint inhibitors treatment. [PDF]

BMC Cardiovasc Disord
Shang C, Wang H, Chen J, Cao S, Sun Y, Sheng Z, Chu T, Zhao L.   +7 more
europepmc   +1 more source

Use of Angiotensin Receptor-Neprilysin Inhibitors (ARNis) in High-Output Heart Failure in a Young Hemodialysis Patient: Synergistic or Cumulative Effect? [PDF]

Cureus
Silva SR, Soares E, Natário A, Gama A, Bernardo T.   +4 more
europepmc   +1 more source

Investigating the binding potential of the Melissa officinalis oil against Alzheimer's targets by molecular docking and in vitro evaluations. [PDF]

Sci Rep
Kolouei A, Barati M, Abbas-Mohammadi M.
europepmc   +1 more source

Pediatric Heart Failure Pharmacotherapy: Transformative Insights for the Future. [PDF]

Rev Cardiovasc Med
Das BB.
europepmc   +1 more source